CoChat

Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy: Results From the Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT)

Open access
Birnie, David H., Ha, Andrew, Higginson, Lyall, Sidhu, Kiran, Green, Martin, Philippon, François, Thibault, Bernard, Wells, George, Tang, Anthony · 2013 · Circulation: Heart Failure
Cited by 155

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background—: The impact of QRS morphology and duration on the effectiveness of cardiac resynchronization therapy (CRT) has been usually assessed separately. The interaction between these 2 simple ECG parameters and their effect on CRT has not been systematically assessed in a large-scale clinical trial. Methods and Results—: The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial showed that implantable cardioverter defibrillator-CRT was associated with a significant reduction in the primary end point of all-cause mortality or heart failure hospitalization. For this substudy, we excluded patients in atrial fibrillation and those with a previous pacemaker. All baseline ECGs were reviewed by a panel of 3 experienced electrocardiographers. A total of 1483 patients were included in this study. Of these, 1175 had left bundle-branch block (LBBB) and 308 had non-LBBB. In patients with LBBB receiving implantable cardioverter defibrillator-CRT, there was a reduction in the primary outcome and in each individual component of the primary outcome. Furthermore, there was continuous relationship between QRS duration and extent of benefit. In patients with non-LBBB and QRS ≥160 ms, the hazard ratio for the primary outcome was 0.52 (0.29–0.96; P =0.033); in patients with QRS <160 ms, the hazard ratio was 1.38 (0.88–2.14; P =0.155). Conclusions—: In patients with LBBB, there was a continuous relationship between broader QRS and greater benefit from implantable cardioverter defibrillator-CRT. However, our data do not support the use of implantable cardioverter defibrillator-CRT in patients with non-LBBB, especially when the QRS duration is <160 ms. There may be some delayed benefit when the QRS is ≥160 ms, but this needs further investigation. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00251251.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.113.000380

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 155

Metadata

Authors
Birnie, D. H., Ha, A., Higginson, L., Sidhu, K., Green, M., Philippon, F., Thibault, B., Wells, G., & Tang, A.
Venue
Circulation: Heart Failure
Published
2013-11
Volume
6
Issue
6
Pages
1190-1198
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2141629047
Cited by
155
References
5
FWCI
11.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy: Results From the Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT). https://app.cochat.ai/papers/10.1161/circheartfailure.113.000380
The paper
Birnie, D. H., Ha, A., Higginson, L., Sidhu, K., Green, M., Philippon, F., Thibault, B., Wells, G., & Tang, A. (2013). Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy: Results From the Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.113.000380

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.